All Q1 FY27 results →
SC

Sudarshan Chem.

Q1 FY27Chemicals & Petrochemicals

Sudarshan Chemical Industries Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹1,138
Market cap₹9.1K Cr
P/E89.2
Updated16 Oct 2026
Read3 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion. Sudarshan Chemical aims for significant growth, targeting a turnover of over Rs.12,000 Crores plus in the medium term (Slide 9 referenced).

From Sudarshan Chem.'s Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Moderate growth
  • Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion.
  • Current market share limits growth beyond overall market size, but there is substantial opportunity in regaining lost business.
  • Target to exceed Rs.12,000 Crores in topline, combining legacy and acquired businesses.
  • Legacy Sudarshan business expected to grow at 12-13%.
  • Focus on profitable growth, maintaining/growing gross margins with premium products.
  • Revenue CAGR of 5-7% over next 2-3 years anticipated, comprising both volume and value growth.
  • Confidence to grow at 2 to 2.5 times the industry growth rate due to lost business recovery and value capture initiatives.

2 more points from Sudarshan Chem.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Sudarshan Chem. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • No substantial new capex is expected in the near term as current capacities are sufficient for projected growth.
  • Moderate capex may be undertaken for special initiatives such as backward integration or product development projects, based strictly on ROI.
  • The company is progressing with Project Integra (One SAP) to integrate and harmonize reporting systems, expected to go live within the financial year.

2 more points from Sudarshan Chem.'s call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sudarshan Chem. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Sudarshan Chem. said on order book & pipeline — free account, 30 seconds.

Sudarshan Chem. — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst Ltd (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

  • IVP Ltd (Q1 FY27)

    Revenue from Operations for Q1 FY27 was ₹154.73 crore, up 12% year-on-year from ₹138.19 crore in Q1 FY26. Key investor presentation takeaways from IVP's Q1 FY27

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sudarshan Chem. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sudarshan Chem. Q1 FY27 results?

Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion. Sudarshan Chemical aims for significant growth, targeting a turnover of over Rs.12,000 Crores plus in the medium term (Slide 9 referenced).

What is Sudarshan Chem. share price analysis?

Sudarshan Chem. currently shows a below-average growth signal. The stock trades at a P/E of 89.2 with a market cap of ₹9,063 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sudarshan Chem. planning capital expenditure?

No substantial new capex is expected in the near term as current capacities are sufficient for projected growth.

Keep Sudarshan Chem. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.